单位:[1]Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.华中科技大学同济医学院附属同济医院外科学系胆胰外科
Pancreatic adenocarcinoma (PAAD) is a highly aggressive and metastatic cancer characterized by poor survival rates. Long non-coding RNAs (lncRNAs) play important roles in various biological processes, including cancer and PAAD. To identify the specific lncRNAs associated with PAAD and analyze their function, we constructed a global triple network based on the competitive endogenous RNA (ceRNA) theory and RNA-seq data from The Cancer Genome Atlas. Using 182 PAAD cases, we established a lncRNA-miRNA-mRNA co-expression network, which was composed of 43 lncRNA nodes, 253 mRNA nodes, 11 miRNA nodes, and 475 edges. Six lncRNAs in the ceRNA network were closely related to overall survival, and a three-lncRNA signature predicted survival of PAAD patients. Protein-protein interaction network data revealed that five genes were associated with overall survival. These results provide novel insight into the function of a lncRNA-associated ceRNA network in the pathogenesis of PAAD, and indicate that the identified three-lncRNA signature may serve as an independent prognostic marker in PAAD.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|2 区医学
小类|2 区肿瘤学3 区细胞生物学
最新[2025]版:
无
第一作者:
第一作者单位:[1]Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
推荐引用方式(GB/T 7714):
Shi Xiuhui,Zhao Yan,He Ruizhi,et al.Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.[J].Oncotarget.2018,9(36):24248-24259.doi:10.18632/oncotarget.24443.
APA:
Shi Xiuhui,Zhao Yan,He Ruizhi,Zhou Min,Pan Shutao...&Qin Renyi.(2018).Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma..Oncotarget,9,(36)
MLA:
Shi Xiuhui,et al."Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.".Oncotarget 9..36(2018):24248-24259